Logo of bmccancBioMed Central web sitethis articleSearchManuscript submissionRegistrationJournal front page
PMC full text:
Published online 2014 Mar 28. doi: 10.1186/1471-2407-14-229

Table 3

Potential determinants for breast density and tumour detection

Factor
Category
Breast density
 
 
 
Fatty (n = 93)
Moderate (n = 312)
Dense (n = 214)
 
  Number (column percent) Mean, SD in italics p-value**
Age at baseline
Years
60.1 (7.1)
56.8 (6.8)
55.1 (6.7)
<0.0001
Age at diagnosis
Years
67.4 (7.3)
65.2 (7.1)
62.0 (7.6)
< 0.0001
HRT at diagnosis
No
25 (26.9)
126 (40.4)
46 (21.5)
<0.0001
 
Yes
10 (10.8)
84 (26.9)
106 (49.5)
 
 
Unknown
58 (62.4)
102 (32.6)
62 (29.0)
 
Menopausal status at diagnosis
Premenopausal
3 (3.2)
18 (5.8)
32 (15.0)
0.001
 
Postmenopausal
89 (95.7)
287 (92.0)
177 (82.7)
 
 
Unknown
1 (1.1)
7 (2.2)
5 (2.3)
 
BMI at baseline
<20
0 (0.0)
10 (3.2)
17 (7.9)
<0.0001
 
20- < 25
29 (31.2)
135 (43.3)
129 (60.3)
 
 
25- < 30
27 (29.0)
123 (39.4)
53 (24.8)
 
 
≥30
37 (39.8)
44 (14.1)
15 (7.0)
 
Detection mode (three categories)
Non-symptomatic
50 (53.8)
183 (58.7)
117 (54.7)
0.333
 
Interval
10 (10.8)
43 (13.8)
34 (15.9)
 
 
Symptomatic
31 (33.3)
83 (26.6)
63 (29.4)
 
 
Unknown*
2 (2.2)
3 (1.0)
0 (0.0)
 
Detection mode (symptomatic including interval cancers)
Non-symptomatic
50 (53.8)
183 (58.7)
117 (54.7)
0.559
 Symptomatic43 (46.2)129 (41.3)97 (45.3) 

*Unknown if interval or symptomatic cancer.

**Continuous variables analysed with ANOVA and categorical variables with the Chi-2 test.